This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (36)  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in this journal  Topic Collections  • Public Health  • Obesity  • Bariatric Surgery  • Alert me on articles by topic  Social Bookmarking   What's this?

Paul E. O'Brien, MD, FRACS; John B. Dixon, MBBS, FRACGP

Arch Surg. 2003;138:376-382.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

INTRODUCTION

The epidemic of obesity requires an intervention that is both effective and broadly acceptable. Conventional medical programs have been ineffective. Traditional surgical approaches, such as gastric bypass and biliopancreatic diversion, are accepted by less than 1% of the severely obese each year. Laparoscopic adjustable gastric banding (LAGB) has been in clinical use for 8 years and it is timely to look at the developments in technique and to look at the outcomes for safety, effectiveness, and acceptability. Data are based on our clinical experiences and research reports derived from 1145 patients treated to date by laparoscopic adjustable gastric banding. We have also drawn on the published literature and on a systematic review of the literature about LAGB published by the Australian Safety and Efficacy Register of New Interventional Procedures–Surgical. Generally reports that have included more than 100 patients and 3 . . . [Full Text of this Article]

EVOLUTION OF TECHNIQUE FOR LAGB AND FOLLOW-UP

OUTCOMES AFTER LAGB

Early Complications and Deaths

Late Complications

WEIGHT LOSS

IMPROVEMENTS IN HEALTH AND QOL

Type 2 DM

Hypertension

Dyslipidemia

Asthma

Gastroesophageal Reflux Disease

Sleep Disordered Breathing

Pregnancy

CHANGE IN QOL

ATTRIBUTES OF THE LAGB

THE CHALLENGE

From the Department of Surgery, Monash University, The Alfred Hospital, Melbourne, Australia. Both authors have received support from Inamed Health, manufacturer of the BioEnterics Lap-Band System, and from US Surgical, manufacturer of stapling instruments. They also receive funds from teaching programs for surgeons and physicians in the placement of the Lap-Band.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

RELATED ARTICLE

This Month in Archives of Surgery
Arch Surg. 2003;138(4):353.
FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Surgery for obesity in older women
Miller and Kral
Menopause Int 2008;14:155-162.
ABSTRACT | FULL TEXT  

Impact of Gastric Bypass Surgery on Gut Hormones and Glucose Homeostasis in Type 2 Diabetes
Naslund and Kral
Diabetes 2006;55:S92-S97.
ABSTRACT | FULL TEXT  

Role of a Minimally Invasive Approach in the Management of Laparoscopic Adjustable Gastric Banding Postoperative Complications
Silecchia et al.
Arch Surg 2004;139:1225-1230.
ABSTRACT | FULL TEXT